Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is Microsoft Corporation (MSFT)’s Restructuring Doomed to Fail?

Even as regulators begin to bear down on too-big-to-fail institutions, JPMorgan Chase & Co. (NYSE:JPM) and Wells Fargo & Co (NYSE:WFC), two of the largest U.S. banks, flexed their muscles in their earnings reports. Both beat the consensus estimate by a significant margin: $1.60 versus $1.44 for JPMorgan and $0.98 versus $0.93 for Wells Fargo. For their efforts, both shares are up sharply this morning, and investors can expect the banking sector to outperform today. The news could also help the indexes set another record high today: Due to the national footprint of both these institutions, strong earnings data provides additional evidence that the economy continues to improve.

Despite this, the S&P 500 and the narrower, price-weighted Dow Jones Industrial Average are essentially unchanged this morning. As of 10:05 a.m. EDT, the S&P is down about a point, while the Dow is up a meager 10 points.

Microsoft Corporation (MSFT) Giving Apple Inc. (AAPL) a Run for its ‘Patent Money’

At Microsoft Corporation (NASDAQ:MSFT), Ballmer muddies the waters
Yesterday, Steve Ballmer, CEO of software giant Microsoft, announced a sweeping reorganization of the company’s businesses that is meant to break down the barriers between existing product divisions in order to adapt to the shift toward mobile and “cloud” (i.e., Web-based) computing.

It’s worth a try, I suppose. The company can hardly become more clumsy when it comes to non-PC-based platforms. I love Office products, for example — I use them every day — but Microsoft Corporation (NASDAQ:MSFT)’s Web-based Office platform is unwieldy and confusing. I initially wanted to use the cloud version Microsoft Word, but I ultimately gave up on it out of frustration.

I don’t have a problem with a chief executive reversing strategic direction, particularly in the technology industry, which moves at warp speed. And there is a certain logic to the new organizational structure. My concern is rather more with Steve Ballmer himself: I don’t think he has provided much evidence that he is the right person to continue leading Microsoft Corporation (NASDAQ:MSFT) through another restructuring, if the company is to have any chance of joining the pack of tech front-runners.

Furthermore, the nature of the reorganization compounds an existing problem at Microsoft Corporation (NASDAQ:MSFT): It appears to strip divisional managers of their autonomy and to centralize power at the top level — that is, with Ballmer. That doesn’t exactly send a healthy message for a company that doesn’t have a clearly articulated succession plan.

The article Is Microsoft’s Restructuring Doomed to Fail? originally appeared on

Fool contributor Alex Dumortier, CFA has no position in any stocks mentioned; you can follow him on LinkedIn. The Motley Fool recommends Wells Fargo. The Motley Fool owns shares of JPMorgan Chase, Microsoft, and Wells Fargo.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.